Endothelium Explained

Endothelium
System:Circulatory system
Location:Lining of the inner surface of blood vessels and lymphatic vessels

The endothelium (: endothelia) is a single layer of squamous endothelial cells that line the interior surface of blood vessels and lymphatic vessels. The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. Endothelial cells form the barrier between vessels and tissue and control the flow of substances and fluid into and out of a tissue.

Endothelial cells in direct contact with blood are called vascular endothelial cells whereas those in direct contact with lymph are known as lymphatic endothelial cells. Vascular endothelial cells line the entire circulatory system, from the heart to the smallest capillaries.

These cells have unique functions that include fluid filtration, such as in the glomerulus of the kidney, blood vessel tone, hemostasis, neutrophil recruitment, and hormone trafficking. Endothelium of the interior surfaces of the heart chambers is called endocardium. An impaired function can lead to serious health issues throughout the body.

Structure

The endothelium is a thin layer of single flat (squamous) cells that line the interior surface of blood vessels and lymphatic vessels.

Endothelium is of mesodermal origin. Both blood and lymphatic capillaries are composed of a single layer of endothelial cells called a monolayer. In straight sections of a blood vessel, vascular endothelial cells typically align and elongate in the direction of fluid flow.[1] [2]

Terminology

The foundational model of anatomy, an index of terms used to describe anatomical structures, makes a distinction between endothelial cells and epithelial cells on the basis of which tissues they develop from, and states that the presence of vimentin rather than keratin filaments separates these from epithelial cells.[3] Many considered the endothelium a specialized epithelial tissue.[4]

Function

The endothelium forms an interface between circulating blood or lymph in the lumen and the rest of the vessel wall. This forms a barrier between vessels and tissues and control the flow of substances and fluid into and out of a tissue. This controls the passage of materials and the transit of white blood cells into and out of the bloodstream. Excessive or prolonged increases in permeability of the endothelium, as in cases of chronic inflammation, may lead to tissue swelling (edema). Altered barrier function is also implicated in cancer extravasation.[5]

Endothelial cells are involved in many other aspects of vessel function, including:

Blood vessel formation

The endothelium is involved in the formation of new blood vessels, called angiogenesis.[9] Angiogenesis is a crucial process for development of organs in the embryo and fetus, as well as repair of damaged areas.[10] The process is triggered by decreased tissue oxygen (hypoxia) or insufficient oxygen tension leading to the new development of blood vessels lined with endothelial cells. Angiogenesis is regulated by signals that promote and decrease the process. These pro- and antiangiogenic signals including integrins, chemokines, angiopoietins, oxygen sensing agents, junctional molecules and endogenous inhibitors.[11] Angiopoietin-2 works with VEGF to facilitate cell proliferation and migration of endothelial cells.

The general outline of angiogenesis is

Host immune response

Endothelial cells express a variety of immune genes in an organ-specific manner.[12] These genes include critical immune mediators and proteins that facilitate cellular communication with hematopoietic immune cells.[13] Endothelial cells encode important features of the structural cell immune response in the epigenome and can therefore respond swiftly to immunological challenges. The contribution to host immunity by non-hematopoietic cells, such as endothelium, is called “structural immunity”.[14]

Clinical significance

See main article: Endothelial dysfunction. Endothelial dysfunction, or the loss of proper endothelial function, is a hallmark for vascular diseases, and is often regarded as a key early event in the development of atherosclerosis.[15] Impaired endothelial function, causing hypertension and thrombosis, is often seen in patients with coronary artery disease, diabetes mellitus, hypertension, hypercholesterolemia, as well as in smokers. Endothelial dysfunction has also been shown to be predictive of future adverse cardiovascular events including stroke, heart disease, and is also present in inflammatory disease such as rheumatoid arthritis, diabetes, and systemic lupus erythematosus.[16] [17]

Endothelial dysfunction is a result of changes in endothelial function.[18] [19] After fat (lipid) accumulation and when stimulated by inflammation, endothelial cells become activated, which is characterized by the expression of molecules such as E-selectin, VCAM-1 and ICAM-1, which stimulate the adhesion of immune cells.[20] Additionally, transcription factors, which are substances which act to increase the production of proteins within cells, become activated; specifically AP-1 and NF-κB, leading to increased expression of cytokines such as IL-1, TNFα and IFNγ, which promotes inflammation.[21] [22] This state of endothelial cells promotes accumulation of lipids and lipoproteins in the intima, leading to atherosclerosis, and the subsequent recruitment of white blood cells and platelets, as well as proliferation of smooth muscle cells, leading to the formation of a fatty streak. The lesions formed in the intima, and persistent inflammation lead to desquamation of endothelium, which disrupts the endothelial barrier, leading to injury and consequent dysfunction.[23] In contrast, inflammatory stimuli also activate NF-κB-induced expression of the deubiquitinase A20 (TNFAIP3), which has been shown to intrinsically repair the endothelial barrier.[24]

One of the main mechanisms of endothelial dysfunction is the diminishing of nitric oxide, often due to high levels of asymmetric dimethylarginine, which interfere with the normal L-arginine-stimulated nitric oxide synthesis and so leads to hypertension. The most prevailing mechanism of endothelial dysfunction is an increase in reactive oxygen species, which can impair nitric oxide production and activity via several mechanisms.[25] The signalling protein ERK5 is essential for maintaining normal endothelial cell function.[26] A further consequence of damage to the endothelium is the release of pathological quantities of von Willebrand factor, which promote platelet aggregation and adhesion to the subendothelium, and thus the formation of potentially fatal thrombi.

Angiosarcoma is cancer of the endothelium and is rare with only 300 cases per year in the US.[27] However it generally has poor prognosis with a five-year survival rate of 35%.[28]

Endothelium in cancer

It has been recognised that endothelial cells building tumour vasculature have distinct morphological characteristics, different origin compared to physiological endothelium, and distinct molecular signature, which gives an opportunity for implementation of new biomarkers of tumour angiogenesis and could provide new anti-angiogenic druggable targets.[29]

Endothelium in diet

A healthy diet abundant in fruits and vegetables has a beneficial impact on endothelial function, whilst a diet high in red and processed meats, fried foods, refined grains and processed sugar increases adhesion endothelial cells and atherogenic promoters.[30] High-fat diets adversely affect the endothelial function.[31]

A Mediterranean diet has been found to improve endothelial function in adults which can reduce risk of cardiovascular disease.[32] [33] Walnut consumption improves endothelial function.[34] [35]

Endothelium in Covid-19

In April 2020, the presence of viral elements in endothelial cells of 3 patients who had died of COVID-19 was reported for the first time. The researchers from the University of Zurich and Harvard Medical School considered these findings to be a sign of a general endotheliitis in different organs, an inflammatory response of the endothelium to the infection that can lead or at least contribute to multi-organ failure in Covid-19 patients with comorbidities such as diabetes mellitus, hypertension and cardiovascular disease.[36] [37]

History

In 1865, the Swiss anatomist Wilhelm His first coin the term “endothelium”. In 1958, A. S. Todd of the University of St Andrews demonstrated that endothelium in human blood vessels have fibrinolytic activity.[38] [39]

See also

List of distinct cell types in the adult human body

External links

Notes and References

  1. Larry McIntire . Eskin SG, Ives CL, McIntire LV, Navarro LT . Response of cultured endothelial cells to steady flow . Microvascular Research . 28 . 1 . 87–94 . July 1984 . 6748961 . 10.1016/0026-2862(84)90031-1 .
  2. Langille BL, Adamson SL . Relationship between blood flow direction and endothelial cell orientation at arterial branch sites in rabbits and mice . Circulation Research . 48 . 4 . 481–488 . April 1981 . 7460219 . 10.1161/01.RES.48.4.481 . free .
  3. Web site: Endothelial cell . BioPortal . Stanford University . 2013-09-28 . dead . https://web.archive.org/web/20131002075249/http://bioportal.bioontology.org/ontologies/FMA/?p=classes&conceptid=http%3A%2F%2Fsig.uw.edu%2Ffma%23Endothelial_cell&jump_to_nav=true . 2013-10-02 .
  4. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V . Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease . Circulation . 125 . 14 . 1795–1808 . April 2012 . 22492947 . 3333843 . 10.1161/circulationaha.111.040352 . Jason Kovacic .
  5. Escribano J, Chen MB, Moeendarbary E, Cao X, Shenoy V, Garcia-Aznar JM, Kamm RD, Spill F . 6 . Balance of mechanical forces drives endothelial gap formation and may facilitate cancer and immune-cell extravasation . PLOS Computational Biology . 15 . 5 . e1006395 . May 2019 . 31048903 . 6497229 . 10.1371/journal.pcbi.1006395 . 1811.09326 . 2019PLSCB..15E6395E . free .
  6. Weitz . Jeffrey I. . 2003-04-01 . Heparan sulfate: Antithrombotic or not? . Journal of Clinical Investigation . 111 . 7 . 952–954 . 10.1172/JCI200318234 . 0021-9738 . 12671043. 152594 .
  7. Li X, Fang P, Li Y, Kuo YM, Andrews AJ, Nanayakkara G, Johnson C, Fu H, Shan H, Du F, Hoffman NE, Yu D, Eguchi S, Madesh M, Koch WJ, Sun J, Jiang X, Wang H, Yang X . 6 . Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation . Arteriosclerosis, Thrombosis, and Vascular Biology . 36 . 6 . 1090–1100 . June 2016 . 27127201 . 4882253 . 10.1161/ATVBAHA.115.306964 .
  8. Vestweber D . How leukocytes cross the vascular endothelium . Nature Reviews. Immunology . 15 . 11 . 692–704 . November 2015 . 26471775 . 10.1038/nri3908 . 29703333 .
  9. Griffioen . A. W. . Molema . G. . 2000 . Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation . Pharmacological Reviews . 52 . 2 . 237–268 . 10835101.
  10. 37060495 . 2023 . Dudley . A. C. . Griffioen . A. W. . Pathological angiogenesis: Mechanisms and therapeutic strategies . Angiogenesis . 26 . 3 . 313–347 . 10.1007/s10456-023-09876-7 . 10105163 .
  11. Bouïs D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA . A review on pro- and anti-angiogenic factors as targets of clinical intervention . Pharmacological Research . 53 . 2 . 89–103 . February 2006 . 16321545 . 10.1016/j.phrs.2005.10.006 .
  12. Krausgruber T, Fortelny N, Fife-Gernedl V, Senekowitsch M, Schuster LC, Lercher A, Nemc A, Schmidl C, Rendeiro AF, Bergthaler A, Bock C . 6 . Structural cells are key regulators of organ-specific immune responses . Nature . 583 . 7815 . 296–302 . July 2020 . 32612232 . 7610345 . 10.1038/s41586-020-2424-4 . 220295181 . free . 2020Natur.583..296K .
  13. Armingol E, Officer A, Harismendy O, Lewis NE . Deciphering cell-cell interactions and communication from gene expression . Nature Reviews. Genetics . 22 . 2 . 71–88 . February 2021 . 33168968 . 7649713 . 10.1038/s41576-020-00292-x .
  14. Minton K . A gene atlas of 'structural immunity' . Nature Reviews. Immunology . 20 . 9 . 518–519 . September 2020 . 32661408 . 10.1038/s41577-020-0398-y . 220491226 . free .
  15. Botts SR, Fish JE, Howe KL . Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment . Frontiers in Pharmacology . 12 . 787541 . December 2021 . 35002720 . 8727904 . 10.3389/fphar.2021.787541 . free .
  16. Tsukahara T, Tsukahara R, Haniu H, Matsuda Y, Murakami-Murofushi K . Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma . Molecular and Cellular Endocrinology . 412 . 320–329 . September 2015 . 26007326 . 10.1016/j.mce.2015.05.021 . 10069/35888 . 10454566 . free .
  17. Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, Nishigaki I . The vascular endothelium and human diseases . International Journal of Biological Sciences . 9 . 10 . 1057–1069 . 2013-11-09 . 24250251 . 3831119 . 10.7150/ijbs.7502 .
  18. Iantorno M, Campia U, Di Daniele N, Nistico S, Forleo GB, Cardillo C, Tesauro M . Obesity, inflammation and endothelial dysfunction . Journal of Biological Regulators and Homeostatic Agents . 28 . 2 . 169–176 . April 2014 . 25001649 .
  19. Reriani MK, Lerman LO, Lerman A . Endothelial function as a functional expression of cardiovascular risk factors . Biomarkers in Medicine . 4 . 3 . 351–360 . June 2010 . 20550469 . 2911781 . 10.2217/bmm.10.61 .
  20. Lopez-Garcia E, Hu FB . Nutrition and the endothelium . Current Diabetes Reports . 4 . 4 . 253–259 . August 2004 . 15265466 . 10.1007/s11892-004-0076-7 . 24878288 .
  21. Blake GJ, Ridker PM . Inflammatory bio-markers and cardiovascular risk prediction . Journal of Internal Medicine . 252 . 4 . 283–294 . October 2002 . 12366601 . 10.1046/j.1365-2796.2002.01019.x . 26400610 . free .
  22. Mizuno Y, Jacob RF, Mason RP . Inflammation and the development of atherosclerosis . Journal of Atherosclerosis and Thrombosis . 18 . 5 . 351–358 . 2011 . 21427505 . 10.5551/jat.7591 . free .
  23. Mäyränpää MI, Heikkilä HM, Lindstedt KA, Walls AF, Kovanen PT . Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion . Coronary Artery Disease . 17 . 7 . 611–621 . November 2006 . 17047445 . 10.1097/01.mca.0000224420.67304.4d . 1884596 .
  24. Soni D, Wang DM, Regmi SC, Mittal M, Vogel SM, Schlüter D, Tiruppathi C . Deubiquitinase function of A20 maintains and repairs endothelial barrier after lung vascular injury . Cell Death Discovery . 4 . 60 . 60 . May 2018 . 29796309 . 5955943 . 10.1038/s41420-018-0056-3 .
  25. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ . 6 . Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension . Journal of Hypertension . 23 . 1 . 7–17 . January 2005 . 15643116 . 10.1097/00004872-200501000-00004 .
  26. Roberts OL, Holmes K, Müller J, Cross DA, Cross MJ . ERK5 and the regulation of endothelial cell function . Biochemical Society Transactions . 37 . Pt 6 . 1254–1259 . December 2009 . 19909257 . 10.1042/BST0371254 .
  27. Web site: 2019-02-27. Angiosarcoma - National Cancer Institute. 2021-08-10. www.cancer.gov. en.
  28. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ . Angiosarcoma . The Lancet. Oncology . 11 . 10 . 983–991 . October 2010 . 20537949 . 10.1016/S1470-2045(10)70023-1 .
    • Book: Milosevic V, Edelmann RJ, Fosse JH, Östman A, Akslen LA . Molecular Phenotypes of Endothelial Cells in Malignant Tumors. . Akslen LA, Watnick RS . Biomarkers of the Tumor Microenvironment . 2022 . 31–52 . Springer . Cham . 10.1007/978-3-030-98950-7_3 . 978-3-030-98949-1 .
  30. Defagó MD, Elorriaga N, Irazola VE, Rubinstein AL . Influence of food patterns on endothelial biomarkers: a systematic review . Journal of Clinical Hypertension . 16 . 12 . 907–913 . December 2014 . 25376124 . 4270900 . 10.1111/jch.12431 .
  31. Fewkes JJ, Kellow NJ, Cowan SF, Williamson G, Dordevic AL . A single, high-fat meal adversely affects postprandial endothelial function: a systematic review and meta-analysis . The American Journal of Clinical Nutrition . 116 . 3 . 699–729 . September 2022 . 35665799 . 9437993 . 10.1093/ajcn/nqac153 .
  32. Shannon OM, Mendes I, Köchl C, Mazidi M, Ashor AW, Rubele S, Minihane AM, Mathers JC, Siervo M . 6 . Mediterranean Diet Increases Endothelial Function in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials . The Journal of Nutrition . 150 . 5 . 1151–1159 . May 2020 . 32027740 . 10.1093/jn/nxaa002 . free .
  33. Fatima K, Rashid AM, Memon UA, Fatima SS, Javaid SS, Shahid O, Zehri F, Obaid MA, Ahmad M, Almas T, Minhas AM . 6 . Mediterranean Diet and its Effect on Endothelial Function: A Meta-analysis and Systematic Review . Irish Journal of Medical Science . 192. 1. February 2022 . 105–113 . 35192097 . 10.1007/s11845-022-02944-9 . 9892125 . 247013758 . free .
  34. Mohammadi-Sartang M, Bellissimo N, Totosy de Zepetnek JO, Bazyar H, Mahmoodi M, Mazloom Z . Effects of walnuts consumption on vascular endothelial function in humans: A systematic review and meta-analysis of randomized controlled trials . Clinical Nutrition ESPEN . 28 . 52–58 . December 2018 . 30390893 . 10.1016/j.clnesp.2018.07.009 . 53221430 .
  35. Xiao Y, Huang W, Peng C, Zhang J, Wong C, Kim JH, Yeoh EK, Su X . 6 . Effect of nut consumption on vascular endothelial function: A systematic review and meta-analysis of randomized controlled trials . Clinical Nutrition . 37 . 3 . 831–839 . June 2018 . 28457654 . 10.1016/j.clnu.2017.04.011 . 13930609 .
  36. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H . 6 . Endothelial cell infection and endotheliitis in COVID-19 . Lancet . 395 . 10234 . 1417–1418 . May 2020 . 32325026 . 7172722 . 10.1016/S0140-6736(20)30937-5 .
  37. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G . Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence . Journal of Clinical Medicine . 9 . 5 . 1417 . May 2020 . 32403217 . 7290769 . 10.3390/jcm9051417 . free .
  38. Todd AS . Fibrinolysis autographs . Nature . 181 . 4607 . 495–496 . February 1958 . 13517190 . 10.1038/181495b0 . 4219257 . 1958Natur.181..495T . 1476-4687 .
  39. Todd AS . Localization of Fibrinolytic Activity in Tissues . British Medical Bulletin . 20 . 3 . 210–212 . September 1964 . 14209761 . 10.1093/oxfordjournals.bmb.a070333 . 1471-8391 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Endothelium".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.